Michigan Medicine to resume construction on new 12-story hospital in Ann Arbor
Architectural rendering of the new inpatient hospital on Michigan Medicine's Ann Arbor campus. ANN ARBOR – Michigan Medicine announced it will soon resume construction on a new 12-story hospital that was paused due to the coronavirus pandemic. (Michigan Medicine)With current facilities operating at more than 90% capacity, the new 690,000 gross square foot building will provide adult patients at Michigan Medicine more access. “As a result, all Michigan Medicine inpatient beds will be single private rooms. According to Michigan Medicine, the new facility will include:Family spaces throughout and space for loved ones to visit in each patient room.
Donors endow Michigan Medicine’s hospital dog program
ANN ARBOR – A gift from donors Lainie and Kenny Lipschutz and the Lipschutz Family Fund has made Michigan Medicine’s Paws4Patients a permanent program in the health system. To honor the family’s generosity, the program has been renamed the Lipschutz-Danzansky Family Paws4Patients Program. Established in 2016 with the support of several donor families, the program -- and its four-legged caregivers -- provides support and comfort to Michigan Medicine patients and their families. (Courtesy: Michigan Medicine)The Lipschutzs are also members of the Michigan Medicine C.S. Each dog was matched with Michigan Medicine based on the types of patients that receive care and the health system’s needs.
Metro Detroit family grateful for donations that kept young daughter alive during cancer treatments
Collecting enough blood donations to meet the constant need was a challenge for the American Red Cross before the coronavirus pandemic. That’s why one Metro Detroit family wants to make sure that blood is always there for anyone who needs it. “Without that transfusion, we wouldn’t have been able to make the step two, step three, step four.”Throughout her treatment, blood was critical. The family speaks about their gratitude for her blood donors every day. READ: American Red Cross hosting blood drive in Metro Detroit this weekAppointments are strongly encouraged.
Michigan Medicine, JDRF commit to raise $14M for new diabetes center
ANN ARBOR – Michigan Medicine has partnered with type 1 diabetes research nonprofit JDRF to establish the new JDRF Center of Excellence at the University of Michigan. The goal of the center, through U-M’s Elizabeth Weiser Caswell Diabetes Institute, is to accelerate research to cure type 1 diabetes and to improve lives. Ann Arbor resident Elizabeth Weiser Caswell and her father, Regent Ron Weiser, have made leadership gifts to kickstart the project. “Michigan Medicine is the ideal partner for JDRF,” Caswell said in a news release. “The JDRF Center of Excellence and the Elizabeth Weiser Caswell Diabetes Institute establishes us as one of the premier diabetes centers in the country—and the strongest in the Midwest,” Thomas Gardner, principal investigator of the JDRF Center of Excellence and EWCDI, said in a news release.
The latest migraine treatment may bring you relief
The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. Earlier this year, the FDA recently approved an acute treatment for migraine in adults. Nurtec™ ODT orally disintegrating tablets is a prescription medicine for the acute treatment of migraine in adults. Nurtec ODT is not used as a preventive treatment of migraine. Do not take if you are allergic to Nurtec ODT or any of its ingredients.
Michigan rejects Macomb County sewage treatment lagoon plan
DETROIT Michigan regulators have rejected a suburban Detroit county's plan to convert state waters into an open-air sewage treatment lagoon. The Department of Environment, Great Lakes, and Energy said Friday it had denied Macomb County's application to place the structure at the end of the Chapaton Retention Treatment Basin. Among them: removing illicit sewer connections, addressing failing septic systems and filtering stormwater tributaries to the Chapaton Retention Treatment Basin through upstream green infrastructure projects. Officials said they also had concerns about a potential public nuisance created by an open-air sewage lagoon so close to existing residences, boat launches and a marina. Read more: Looking for coronavirus (COVID-19) clues in Macomb Countys raw sewage
UM study: Immunosuppressive drug associated with lower risk of death in COVID-19 patients
For the study, U-M researchers used data from 154 critically ill Michigan Medicine patients from early March to late April to formulate their conclusions. At the end of 28 days after patients were put on a ventilator, 36% of patients of non-tocilizumab and 18% of tocilizumab patients died. For patients still at the hospital at the end of the study, 82% of tocilizumab patients and 53% of non-tocilizumab patients stopped using a ventilator. However, just over half of the tocilizumab patients developed an additional infection but only 26% of non-tocilizumab patients did. It was only given to 25% of tocilizumab patients and 20% of non-tocilizumab patients.
First drug proves able to improve survival from COVID-19
Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients. The study is a large, strict test that randomly assigned 2,104 patients to get the drug and compared them with 4,321 patients getting only usual care. It reduced deaths by 35% in patients who needed treatment with breathing machines and by 20% in those only needing supplemental oxygen. "The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients. ___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institutes Department of Science Education.
University of Michigan regent, wife donate $30M for new diabetes institute
ANN ARBOR University of Michigan Regent Ron Weiser and his wife, Eileen, have donated $30 million to the university to bolster diabetes research and develop life-changing therapies. The research will be in collaboration with Michigan Medicine and other schools and units within the university. The gift will see the establishment of the Elizabeth Weiser Caswell Diabetes Institute, named for the Weisters daughter whose husband and two sons have Type 1 diabetes. Elizabeth has been a relentless educator and advocate for people with diabetes and for diabetes research, Regent Weiser said in a news release. This gift is transformational, Marschall S. Runge, M.D., Ph.D., executive vice president for medical affairs, dean of the University of Michigan Medical School and CEO of Michigan Medicine said in a news release.
Detroit’s Henry Ford Health to lead first large-scale US study on drug’s effectiveness to prevent COVID-19
DETROIT – Henry Ford Health System will launch the first large-scale U.S. study to determine a drug’s effectiveness in preventing coronavirus (COVID-19). The study of hydroxychloroquine used prophylactically could begin as early as next week, according to Henry Ford. Dr. Marcus Zervos, division head of Infectious Disease for Henry Ford Health System, will oversee this study with Dr. O’Neill. The study medication was specially procured for this study and will not impact the supply of medication for people who already take the medication for other conditions. Henry Ford Health System is poised to do anything we can to help them stay safe.” The FDA will provide the drug directly to Henry Ford Health System physicians to distribute.